141 related articles for article (PubMed ID: 7026328)
1. Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.
Starke A; Keck E; Berger M; Zimmermann H
Diabetologia; 1981 May; 20(5):547-52. PubMed ID: 7026328
[TBL] [Abstract][Full Text] [Related]
2. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects.
Sgambato S; Passariello N; Giugliano D; Torella R; D'Onofrio F
Acta Diabetol Lat; 1981; 18(3):235-41. PubMed ID: 7029989
[TBL] [Abstract][Full Text] [Related]
3. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
5. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
Raskin P; Fujita Y; Unger RH
J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin, a diabetogenic hormone?
Passariello N; Giugliano D; Sgambato S; Torella R; D'Onofrio F
J Clin Endocrinol Metab; 1981 Aug; 53(2):318-23. PubMed ID: 7019230
[TBL] [Abstract][Full Text] [Related]
8. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ
J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
[TBL] [Abstract][Full Text] [Related]
9. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.
Vella A; Shah P; Basu R; Basu A; Holst JJ; Rizza RA
Diabetes; 2000 Apr; 49(4):611-7. PubMed ID: 10871199
[TBL] [Abstract][Full Text] [Related]
11. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
[TBL] [Abstract][Full Text] [Related]
13. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
14. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-induced increase in plasma potassium levels in type 1 (insulin-dependent) diabetic subjects.
Cagliero E; Martina V; Massara F; Molinatti GM
Diabetologia; 1983 Feb; 24(2):85-7. PubMed ID: 6132848
[TBL] [Abstract][Full Text] [Related]
16. The effects of glucagon administration to nondiabetics and diabetics.
Unger RH; Aydin I; Nakabayashi H; Srikant CB; Raskin P
Metabolism; 1976 Nov; 25(11 Suppl 1):1523-6. PubMed ID: 979658
[No Abstract] [Full Text] [Related]
17. Free insulin, C-peptide and glucagon profiles in insulin dependent diabetes mellitus.
Scott RS; Espiner EA; Donald RA; Ellis MJ
Aust N Z J Med; 1980 Apr; 10(2):146-50. PubMed ID: 6992759
[TBL] [Abstract][Full Text] [Related]
18. Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects.
Hoogwerf BJ; Bantle JP; Gaenslen HE; Greenberg BZ; Senske BJ; Francis R; Goetz FC
Metabolism; 1986 Feb; 35(2):122-5. PubMed ID: 3511350
[TBL] [Abstract][Full Text] [Related]
19. Glucose metabolism in patients receiving chronic calcitonin treatment.
Guigliano D; Passariello N; Sgambato S; Torella R; Ceriello A; D'Onofrio F
Diabete Metab; 1982 Sep; 8(3):213-6. PubMed ID: 6754493
[TBL] [Abstract][Full Text] [Related]
20. Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
Coppola L; Giugliano D; Tirelli A; Misso L; Sgambato S; D'Onofrio F
Diabete Metab; 1980 Dec; 6(4):245-9. PubMed ID: 6110570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
